SCHEMBL292181

SCHEMBL292181

CC(C)CCC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3631787 0.90 GABRP (0.50)
SCHEMBL1410363 0.83
SCHEMBL16667714 0.82 TSHR (0.48)
SCHEMBL1410503 0.81 ALDH1A1 (0.52)
SCHEMBL2522581 0.80
SCHEMBL19468469 0.79 ALDH1A1 (0.56)
SCHEMBL19468517 0.79 ALDH1A1 (0.56)
SCHEMBL19468512 0.79 ALDH1A1 (0.56)
SCHEMBL19468475 0.79 ALDH1A1 (0.56)
SCHEMBL19468477 0.79 ALDH1A1 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 703 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117777987-A Emulsified acid nanoemulsifier and preparation method and application thereof 江苏金桥油脂科技有限公司 2024-03-29 CN claimed
CN-117106845-A Synthesis method of chiral fused ring [6-5-3] pyridine diol 西安交通大学 2023-11-24 CN claimed
US-20110282074-A1 Process for Preparing Substantially Pure Simvastatin Sterling Biotech Research Center a Corporate Research Centre of Sterling Biotech Limited (IN) 2011-11-17 US claimed
WO-2005077928-A1 IMPROVED PROCESS FOR PRODUCING SIMVASTATIN JUBILANT ORGANOSYS LIMITED (IN) 2005-08-25 WO claimed
US-20030225161-A1 GABA and L-glutamic acid analogs for antiseizure treatment NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-12-04 US claimed
EP-0641330-A4 GABA AND L-GLUTAMIC ACID ANALOGS FOR ANTISEIZURE TREATMENT. UNIV NORTHWESTERN (US) 1997-05-28 EP claimed
EP-0641330-A1 GABA AND L-GLUTAMIC ACID ANALOGS FOR ANTISEIZURE TREATMENT NORTHWESTERN UNIVERSITY (US) 1995-03-08 EP claimed
EP-0235942-B1 Alkylenediamine derivatives NIPPON CHEMIPHAR CO (JP) 1994-03-23 EP claimed
WO-1993023383-A1 GABA AND L-GLUTAMIC ACID ANALOGS FOR ANTISEIZURE TREATMENT NORTHWESTERN UNIVERSITY (US) 1993-11-25 WO claimed
US-4123447-A REACTING (1,5-CYCLOOCTADIENE)BIS(TRIETHYLPHOSPHINE)-NICKEL(O) WITH AN ACYL HALIDE, OLIGOMERIZATION CATALYSTS PHILLIPS PETROLEUM COMPANY (US) 1978-10-31 US claimed
CN-119707952-B Thiadiazolidinone derivative with PTPN2/PTPN1 inhibitory activity, and preparation method and application thereof CHINA PHARMACEUTICAL UNIVERSITY (CN) 2026-05-26 CN disclosed
CN-117720466-B 2 '-Acetyl-2', 3 '-dihydro-4'H-spiro [ cyclohexane-1, 1 '-isoquinoline ] -4' -ketone compound and preparation method and application thereof 承德医学院 2026-05-19 CN disclosed
CN-122055369-A Bridged tricyclic carbamoyl pyridone compounds and uses thereof 吉利德科学公司 2026-05-15 CN disclosed
US-20260070932-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON INC (US) 2026-03-12 US disclosed
CN-120424083-B Pyrrolo pyrimidine compound and preparation method and application thereof 江西省肿瘤医院(江西省第二人民医院、江西省癌症中心) 2026-02-27 CN disclosed
US-4277605-A ANTIDIARRHEA AGENTS BRISTOL-MYERS COMPANY (US) 1981-07-07 US disclosed
US-4277427-A DISTRIBUTION OF RESINOUS FLAKES CONTAINING A BLOWING AGENT SUPPRESSOR ON A PRINTED, GELLED, FOAMABLE POLYMER CONGOLEUM CORPORATION (US) 1981-07-07 US disclosed
US-4173541-A ANITOXIDANTS CINCINNATI MILACRON CHEMICALS INC. (US) 1979-11-06 US disclosed
US-4148794-A INTERMEDIATES FOR HEXAHYDRO-2,6-METHANO-3-BENZAZOCINES STERLING DRUG INC. (US) 1979-04-10 US disclosed
US-4119628-A Process for preparing hexahydro-11 (eq)-CH2 CH2 COR5 -2,6-methano-3-benzazocines STERLING DRUG INC. (US) 1978-10-10 US disclosed